Buparlisib experimental drug molecule

Bildnummer 11731926
Buparlisib experimental drug molecule
Buparlisib. Molecular model of the experimental cancer drug Buparlisib. Buparlisib is a phosphoinositide 3-kinase inhibitor (PI3K inhibitor) undergoing clinical trials for treatment of advanced endocrine-resistant breast cancer. PI3K inhibitors are a class of drugs that function by inhibiting one or more of the phosphoinositide 3-kinase enzymes,which are important in signalling pathways for many cellular functions. These include growth control,metabolism and translation of genes into proteins. Inhibition of any of these processes can result in tumour suppression. Atoms are represented as spheres and are colour-coded: carbon (grey),hydrogen (white),nitrogen (blue),oxygen (red) and iron (green)
Lizenzart: Lizenzpflichtig
Credit: Science Photo Library / Evans, Dr. Tim
Bildgröße: 4680 px × 3744 px
Modell-Rechte: nicht erforderlich
Eigentums-Rechte: nicht erforderlich
Restrictions: -

Preise für dieses Bild ab 15 €

Universitäten & Organisationen
(Informationsmaterial Digital, Informationsmaterial Print, Lehrmaterial Digital etc.)
ab 15 €
Redaktionell
(Bücher, Bücher: Sach- und Fachliteratur, Digitale Medien (redaktionell) etc.)
ab 30 €
Werbung
(Anzeigen, Aussenwerbung, Digitale Medien, Fernsehwerbung, Karten, Werbemittel, Zeitschriften etc.)
ab 55 €
Handelsprodukte
(bedruckte Textilie, Kalender, Postkarte, Grußkarte, Verpackung etc.)
ab 75 €
Pauschalpreise
Rechtepakete für die unbeschränkte Bildnutzung in Print oder Online
ab 495 €

Keywords

;